Hanx Biopharmaceuticals (Wuhan) Co., Ltd. (HKG:3378)
Hong Kong · Delayed Price · Currency is HKD 19.16
+0.36 (1.91%)
Feb 13, 2026, 4:08 PM HKT
HKG:3378 Revenue
In the year 2024, Hanx Biopharmaceuticals (Wuhan) had annual revenue of 2.20M CNY, down -13.39%.
Revenue
2.20M CNY
Revenue Growth
-13.39%
P/S Ratio
1,115.31
Revenue / Employee
39.98K CNY
Employees
55
Market Cap
2.61B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.20M | -340.00K | -13.39% |
| Dec 31, 2023 | 2.54M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition